GreenStar Biosciences Corp.

Recent News

• GreenStar Biosciences Announces Filing of Fourth Provisional Patent Application

  Vancouver, British Columbia--(Newsfile Corp. - August 5, 2020) - GreenStar Biosciences Corp. (CSE: GSTR) (OTC Pink: GTSIF) ("GreenStar" or the "Company") is pleased to announce that its wholly-owned subsidiary, Eleusian Biosciences Corporation ("Eleusian"), has filed a new provisional patent application, adding to the overall existing intellectual property portfolio of the...

  2020-08-05 8:30 AM ET
• GreenStar Biosciences' Partner Cowlitz Reports Revenues for Q1 2020

  Vancouver, British Columbia--(Newsfile Corp. - July 29, 2020) - GreenStar Biosciences Corp. (CSE: GSTR) (OTC Pink: GTSIF) ("GreenStar" or the "Company"), is pleased to announce that its tenant partner Cowlitz County Cannabis Cultivation Inc. ("Cowlitz") has generated over US$6.58 million in gross sales revenues for the three months ended...

  2020-07-29 8:30 AM ET
• GreenStar Biosciences Completes Acquisition of 100% of Eleusian Biosciences Corp. and Appoints Jonathan Gilbert to Board of Directors and Maghsoud Dariani as Chief Science Officer

  Vancouver, British Columbia--(Newsfile Corp. - July 27, 2020) - GreenStar Biosciences Corp. (CSE: GSTR) (OTC Pink: GTSIF) ("GreenStar" or the "Company") is pleased to announce, further to its press release dated July 21, 2020, that it has completed the acquisition of 100% of Toronto, Ontario-based Eleusian Biosciences Corp. ("Eleusian")...

  2020-07-27 9:00 AM ET
• GreenStar Biosciences Announces Filing of Third Provisional Patent Application by Eleusian Biosciences

  Vancouver, British Columbia--(Newsfile Corp. - July 23, 2020) -  GreenStar Biosciences Corp. (CSE: GSTR) (OTC Pink: GTSIF) ("GreenStar" or the "Company") is pleased to announce that Eleusian Biosciences Corporation ("Eleusian") has added to its existing intellectual property portfolio by filing a third provisional patent application. This application further expands...

  2020-07-23 7:59 AM ET
• GreenStar Biosciences Announces Closing of Private Placement and Debt Settlement

  Vancouver, British Columbia--(Newsfile Corp. - July 23, 2020) - GreenStar Biosciences Corp. (CSE: GSTR) (OTC Pink: GTSIF) ("GreenStar" or the "Company"), is pleased to announce that it has closed a non-brokered private placement of common shares for gross proceeds of $585,000 (the "Offering"). The Offering consisted of the...

  2020-07-23 7:50 AM ET
• GreenStar Biosciences Signs Definitive Agreement to Acquire 100% of Eleusian Biosciences Corp.

  Vancouver, British Columbia--(Newsfile Corp. - July 21, 2020) -  GreenStar Biosciences Corp. (CSE: GSTR) (OTC Pink: GTSIF) ("GreenStar" or the "Company") is pleased to announce, further to its press release dated June 16, 2020, that it has signed a definitive binding share exchange agreement dated July 20, 2020 (the "Agreement")...

  2020-07-21 9:00 AM ET
• GreenStar Biosciences Announces Non-Brokered Private Placement and Debt Settlement

  Vancouver, British Columbia--(Newsfile Corp. - July 20, 2020) - GreenStar Biosciences Corp. (CSE: GSTR) (OTC Pink: GTSIF) ("GreenStar" or the "Company"), is pleased to announce that it will proceed with a non-brokered private placement of common shares to raise gross proceeds of up to $585,000 (the "Offering"). The...

  2020-07-20 9:00 AM ET
• GreenStar Biosciences: Jonathan Gilbert, Eleusian Biosciences CEO, to Speak at Peak Asset Management's Psychedelic Investment Webinar

  Vancouver, British Columbia--(Newsfile Corp. - June 17, 2020) - Eleusian CEO, Jonathan Gilbert, will be speaking at the Peak Asset Management's Psychedelic Investment Webinar this Thursday, June 18th at 7:30PST. The Webinar is titled: "Psychedelic Stocks On The Charge in North America Creates Opportunities for Global Investors" and is...

  2020-06-17 1:53 PM ET